E.e.s Granule, For Suspension
Product Images NDC 80005-152

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for E.e.s (NDC 80005-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Carnegie Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Ees 01)

FDA Label Image

Principal Display Panel (400 mg Tablet Bottle Label)

Principal Display Panel (400 mg Tablet Bottle Label)
This text describes the usage and precautions of Erythromycin Ethylsuccinate tablets, USP 400 mg. It provides instructions on storing the tablets, their composition, adult dosage, administration without meals, and warnings to keep them out of reach of children. Additionally, it mentions the manufacturer, Camegie Pharmaceuticals LLC, and includes the address in Delran, NJ 08075, USA.*
FDA Label Image

Principal Display Panel (100 mL Bottle Label)

Principal Display Panel (100 mL Bottle Label)
This document contains information regarding the space required for the serialization of a medication called E.E.S Granules, which is Erythromycin Ethylsuccinate for oral suspension. The text provides details on the preparation and usage of the medication, including directions for mixing, dosage instructions, and storage recommendations. It also mentions that the medication can be taken without regard to meals and needs to be used within 10 days after preparation.*
FDA Label Image

Principal Display Panel (200 mL Bottle Label)

Principal Display Panel (200 mL Bottle Label)
This is a medication label for Erythromycin Ethylsuccinate oral suspension. The label provides information on the space required for serialization, dosage instructions, storage conditions, and directions for mixing the suspension. It mentions that the suspension contains 200 mg of Erythromycin per 5 mL when reconstituted, and includes details on the dosage for children and adults. The product is manufactured by Carnegie Pharmaceuticals LLC in Delran, NJ, USA.*
FDA Label Image

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.